Levetiracetam in Sodium Chloride Injection

Hazard statements (CLP)

H336, H361, H362

Code

Statements

H336

May cause drowsiness or dizziness

H361

Suspected of damaging fertility or the unborn child

H362

May cause harm to breast-fed children

SECTION 2: Hazards identification

Classification of the Substance or Mixture GHS-US Classification Reproductive toxicity, Category 2 H361 Reproductive toxicity, Additional category, Effects on or via lactation H362 Specific target organ toxicity – Single exposure, Category 3, Narcosis H336

2.2 Label elements

GHS-US Labeling

Hazard pictograms

GHS07 GHS08

Signal word

Warning

Hazard statements

H336 - May cause drowsiness or dizziness. H361 - Suspected of damaging fertility or the unborn child (oral). H362 - May cause harm to breast-fed children.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe mist, spray, or vapors. P263 - Avoid contact during pregnancy and while nursing. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear eye protection, protective gloves and clothing. P304+P340 - If inhaled: Remove person to fresh air and keep at rest in a position comfortable for breathing. P308+P313 - If exposed or concerned: Get medical advice/attention. P312 - Call a poison center or doctor if you feel unwell. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P405 - Store locked up. P501 - Dispose of contents and/or container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulations. 2.3 Hazards associated with known or reasonably anticipated uses This product is a pharmaceutical product designed for administration to a patient by a qualified medical professional. No other uses are anticipated. If this product is used in unforeseeable chemical processes and not used as intended or reasonable, the hazards listed in Section 2.3 cannot cover all chemistries. Therefore, a Process Hazard Analysis (PHA) or other hazard assessment for additional specific end uses should be performed to ensure that hazards are fully understood, and adequate safety measures are in place. See Section 10 for relevant reactivity and stability information.

Other hazards

Exposure may aggravate pre-existing eye, skin, or respiratory conditions

Ingredient(s) with unknown acute toxicity

No data available

2.1 Classification of the substance or mixture

GHS-US Classification Reproductive toxicity, Category 2 H361 Reproductive toxicity, Additional category, Effects on or via lactation H362 Specific target organ toxicity – Single exposure, Category 3, Narcosis H336